Insurances & Business

Daiichi to Pay Up to $4.6 Billion For Control of Ranbaxy

Investment | Sources: bnet.com

Similar/Related/News:

• Pfizer May Make Counter Bid For Ranbaxy: Report
MUMBAI (Reuters) - Pfizer Inc <PFE.N> may bid for Ranbaxy Laboratories Ltd <RANB.BO>, countering a $4.6 billion offer by Japan's Daiic...
• Gazprom to Buy Control of TNK-BP For $20 Billion: Report
MOSCOW (Reuters) - Russia's gas export monopoly Gazprom <GAZP.MM> will buy majority control of oil major TNK-BP <TNBPI.MM>, which is h...
• India’s Ranbaxy Falls Nearly 7 Percent After Lipitor Deal
NEW DELHI (Reuters) - Shares in Indian drugmaker Ranbaxy Laboratories Ltd <RANB.BO> fell nearly 7 percent on Thursday morning, after a paten...
• Ranbaxy May Use M&A to Grow in Japan Generics Market
TOKYO (Reuters) - India's Ranbaxy Laboratories Ltd <RANB.BO> sees tremendous opportunities for growth in Japan's generics drug market and me...
• Massachusetts Employers, Insurers Lobby Against Higher Employer Fees For Uninsured Workers, Support Cost Control Efforts
Massachusetts businesses and most of the state's health insurers on Wednesday announced the formation of the Coalition for Affordable Health Coverage,...
• Canada Blocks Sale of Satellite Firm to Alliant
OTTAWA (Reuters) - The Canadian government said on Thursday it had blocked the $1.325 billion sale of sensitive satellite technology to U.S. rocke...
• Price Stability Should Remain Key: Fed’s Plosser
CAPE TOWN (Reuters) - The best way for central banks to foster sustainable economic growth and prevent instability is to keep inflation under cont...
• Airbus Sees No Negotiated Settlement With Boeing
GENEVA (Reuters) - European planemaker Airbus does not expect an early resolution of its disputes about state aid with U.S. rival Boeing, even tho...